Jonathan Ejie | Personalized Medicine | Best Research Article Award

Jonathan Ejie | Personalized Medicine | Best Research Article Award

Mr. Jonathan Ejie, UCSF, United States

Mr. Jonathan Ejie is an aspiring physician-scientist currently pursuing his M.D. at UCSF 🩺 (Class of 2026), following a B.S. in Electrical Engineering & Computer Science from UC Berkeley 💻. His research spans oncology, radiology, and AI in healthcare, with published work in Cancers (2025) and upcoming studies in Nature Communications 📊. Jonathan integrates data science 🧠 with clinical insights, contributing to health equity, quality improvement, and surgical education. A mentor, tutor, and award-winning leader 🏅, he co-founded the UCSF Futbol Club and serves underserved communities through advocacy and outreach.

Publication Profile 

Orcid

Education

Mr. Jonathan Ejie is an exceptional scholar whose educational journey bridges medicine and technology. He is currently pursuing his Doctor of Medicine (M.D.) degree at the prestigious University of California, San Francisco (UCSF) 🏥, with an expected graduation in 2026. Prior to this, he earned a Bachelor of Science in Electrical Engineering and Computer Science (EECS) 💻 from the University of California, Berkeley, graduating in 2022. His strong foundation in both engineering and clinical science equips him with a unique interdisciplinary perspective 🤖🩺, positioning him at the forefront of innovation in digital health and precision medicine.

Experience

Mr. Jonathan Ejie brings a blend of academic support and compassionate service to his professional journey. As an MCAT Physics Tutor at UCSF (2023), he guided 15+ students through complex physics concepts 📘⚛️. Earlier, at Contra Costa College (2019–2021), he tutored mathematics from Algebra to Calculus ➕📐. His volunteer work includes providing first aid at athletic events 🏃‍♂️🩹, teaching surgical skills to high school students at UCSF 🧵🧑‍⚕️, and serving as a Health Advocate at West County Health Center 💬🩺, helping underserved patients access vital community resources. His dedication reflects a strong commitment to both education and public health.

Awards

Mr. Jonathan Ejie has been recognized for his academic excellence and impactful contributions to medicine and research. In 2024, he was honored with the prestigious Sinkler Miller Medical Association Scholarship 🎖️, sponsored by Gilead, celebrating his commitment to health equity and academic distinction. He also received the UCSF School of Medicine Summer Explore Fellowship Grant 🌟, supporting his innovative pursuits in medical research. In May 2023, Jonathan earned the Inquiry Conference Travel and Dissemination Award ✈️📊, which enabled him to share his scholarly findings on a larger stage. These accolades reflect his rising potential and leadership in healthcare.

Research Focus 

Mr. Jonathan Ejie’s research focus lies at the intersection of oncology, health disparities, and medical data science. His standout work on the “Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer” 📉🩺 highlights critical inequities in healthcare delivery across race, geography, and insurance status. Combining his background in medicine 🧑‍⚕️ and computer science 💻, Jonathan leverages data analysis and machine learning 🤖📊 to drive systemic improvements in cancer care. His work reflects a commitment to equity, evidence-based medicine, and the pursuit of personalized, accessible treatment strategies for vulnerable cancer populations.

Publication Top Notes

  • Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer

Mario Romeo | Precision Medicine | Best Researcher Award

Mario Romeo | Precision Medicine | Best Researcher Award

Dr. Mario Romeo, Dipartimento di Medicina di Precisione, Università degli Studi della Campania, LuigiVanvitelli, Italy

Dr. Mario Romeo is an accomplished medical doctor and researcher specializing in Digestive System Diseases. Graduating with top honors in Medicine and Surgery from the University of Campania “Luigi Vanvitelli” 🎓, he also earned a specialization in Gastroenterology and is pursuing a Ph.D. in Clinical and Experimental Medical Sciences. His research spans gut microbiota 🧫, liver disease 🏥, and metabolic dysfunction. A recipient of over 20 international awards 🏆, Dr. Romeo is widely recognized for his groundbreaking work in hepatology and gastroenterology. He actively contributes to scientific societies and fosters innovation in digestive health care.

Publication Profile 

Orcid

Education

Dr. Mario Romeo 🎓 began his academic journey with honors, earning his Diploma di Maturità Classica from Liceo Classico Gneo Nevio in June 2014 with a perfect score of 100/100 con lode 📜. He continued his excellence at the University of Campania “Luigi Vanvitelli,” completing his Laurea in Medicina e Chirurgia in July 2020 with 110/110 con lode 🩺, presenting a thesis on sarcopenia in compensated liver cirrhosis. He further specialized in Digestive System Diseases, earning his diploma in January 2025 with 50/50 con lode 🌟. His thesis explored RPR as a non-invasive tool in liver disease prediction.

Awards

Dr. Mario Romeo 🏅 has received numerous prestigious scholarships and awards in recognition of his excellence in hepatology and gastroenterology. Highlights include competitive fellowships like the AISF MasterClass 2022 🎓 and UEG Clinical Visiting Fellowship 2025 🌍. He has earned multiple travel grants ✈️ and best presentation prizes 🏆 at top events such as UEG Week, FISMAD, EASL, and ESCI for groundbreaking research on liver diseases, MAFLD, gut microbiota, and non-invasive biomarkers. His multidisciplinary “CoCoNut” protocol 🍏 also gained international acclaim. These accolades affirm his dynamic role in advancing liver research and patient care through innovation and collaboration.

Research Focus 

Dr. Mario Romeo’s research focus lies predominantly in Hepatology and Gastroenterology, with a strong emphasis on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), liver cirrhosis, and gut-liver axis dynamics 🧬🍽️. His work explores non-invasive biomarkers, body composition, oxidative stress, and gut microbiota 🧫, highlighting their roles in disease progression and clinical outcomes. He also investigates multidisciplinary management strategies combining nutritional, psychological, and pharmacological interventions 🥗🧠💊. Dr. Romeo contributes significantly to understanding liver-related complications like sarcopenia, dysgeusia, and hepatocellular carcinoma 🎯. His innovative, patient-centered research enhances predictive diagnostics and therapeutic approaches in chronic liver diseases.

Publication Top Notes

  • Spleen Area Affects the Performance of the Platelet Count–Based Non-invasive Tools in Predicting First Hepatic Decompensation in Metabolic Dysfunction–Associated Steatotic Liver Disease Cirrhosis
  • Nutritional and Psychological Support as a Multidisciplinary Coordinated Approach in the Management of Chronic Liver Disease: A Scoping Review
  • Letter: Different Risk of Acute Variceal Bleeding According to the Liver Disease Aetiology in Decompensated Cirrhosis Patients Receiving Carvedilol‐Based Primary Prophylaxis—May Insulin Resistance Unloose This Gordian Knot?
  • Exploring the Classic and Novel Pathogenetic Insights of Plastic Exposure in the Genesis and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
  • The Role of the Gut–Biliary–Liver Axis in Primary Hepatobiliary Liver Cancers: From Molecular Insights to Clinical Applications
  • Primary biliary cholangitis, Celiac Disease, and MASLD: the triumvirate of steatosis. How should we manage this triple overlap?
  • Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)?
  • FLAME: Training and Validating a Newly Conceived Model Incorporating Alpha-Glutathione-S-Transferase Serum Levels for Predicting Advanced Hepatic Fibrosis and Acute Cardiovascular Events in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
  • Dysgeusia in MASLD-related advanced chronic liver disease (ACLD): a silent driver towards the “Bermuda” triangle of malnutrition-sarcopenia-frailty severely affecting prognosis
  • Vanek’s Tumour as a Rare Cause of Dyspeptic Syndrome in a Patient with Primary Biliary Cholangitis: A Case Report
  • Systemic Oxidative Stress Correlates with Sarcopenia and Pruritus Severity in Primary Biliary Cholangitis (PBC): Two Independent Relationships Simultaneously Impacting the Quality of Life—Is the Low Absorption of Cholestasis-Promoted Vitamin D a Puzzle Piece?
  • Prediction of Clinical Trajectory in HCV-Related ACLD after SVR: Role of Liver Stiffness in a 5-Years Prospective Study

Salma Khan | Precision Medicine | Best Researcher Award

Salma Khan | Precision Medicine | Best Researcher Award

Assoc. Prof. Dr. Salma Khan, Loma Linda University, United States

Assoc. Prof. Dr. Salma Khan is a distinguished physician-scientist specializing in gynecologic oncology and thyroid cancer research. With a Ph.D. from Kumamoto University 🇯🇵 and faculty appointments at Loma Linda University 🏥, she excels in translational cancer biology. Her groundbreaking work on health disparities, molecular oncology, and thyroid cancer genomics has earned her multiple honors, including the 2024 AACR Women Cancer Research Award 🌟. She actively contributes to the American Thyroid Association, NIH peer review panels, and serves on several journal editorial boards 📚. Dr. Khan is also a dedicated mentor and advocate for diversity in science and medicine .

Publication Profile

Google Scholar

Education

Assoc. Prof. Dr. Salma Khan began her academic journey with a Higher Secondary Certificate from Govt. M.M. Ali College, Tangail, Bangladesh (1983–1985). 🎓 She earned her MBBS from Gandhi Medical College, Bhopal, India (1986–1991), followed by an internship at Hamidia Hospital (1991–1992). 🏥 Dr. Khan completed her residency in Obstetrics and Gynecology at IPGMR, Dhaka (1992–1994), and pursued a fellowship at Kumamoto University School of Medicine, Japan (1995–1996). 🌸 Her academic excellence culminated in a Ph.D. in Gynecologic Oncology from Kumamoto University (1996–2000), showcasing her dedication to advancing women’s health.

Awards

Assoc. Prof. Dr. Salma Khan has received numerous accolades throughout her distinguished career. She was honored with the Best Mentor Award by BMANA in 2025 (San Francisco), 2023 (Los Angeles), and 2020 (Dallas). 🌟 In 2024, she received the AACR Women Cancer Research Award and the Best Basic Science Research Award in California. 🎗️ A frequent recipient of Travel Awards from the American Thyroid Association (2016–2023), Dr. Khan also earned top honors at scientific meetings and was a keynote speaker in Japan and Korea (2015). 🌍 Her journey began with prestigious academic scholarships in Bangladesh, India, and Japan.

Research Focus

Assoc. Prof. Dr. Salma Khan focuses her research on cancer biology, with a specialized emphasis on exosomes, survivin biology, and biomarkers for early cancer detection, particularly in prostate and breast cancers. Her groundbreaking studies explore how tumor-derived exosomes contribute to cell signaling, apoptosis inhibition, and metastasis, highlighting survivin as a pivotal player and potential diagnostic marker. Dr. Khan’s work intersects molecular oncology and translational medicine, aiming to bridge lab findings with clinical applications. Her contributions are instrumental in advancing non-invasive diagnostic tools and improving cancer prognosis across diverse populations.

Publication Top Notes

Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer

Survivin is released from cancer cells via exosomes

Early diagnostic value of survivin and its alternative splice variants in breast cancer

Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential

PTEN promoter is methylated in a proportion of invasive breast cancers

Human villous macrophage-conditioned media enhance human trophoblast growth and differentiation in vitro

Differential MicroRNA‐Signatures in Thyroid Cancer SubtypesProteomic profiling of serum-derived exosomes from ethnically diverse prostate cancer patients

Exosomes secreted from human cancer cell lines contain inhibitors of apoptosis (IAP)

LATS1 phosphorylates forkhead L2 and regulates its transcriptional activity

The emerging role of exosomes in survivin secretion

Curcumin induces pancreatic adenocarcinoma cell death via reduction of the inhibitors of apoptosis

juan iovanna | Personalized Medicine | Best Researcher Award

juan iovanna | Personalized Medicine | Best Researcher Award

Prof. Dr. juan iovanna, INSERM, France

Prof. Dr. Juan Iovanna è un medico e ricercatore internazionale esperto in oncologia, specializzato nello studio del carcinoma pancreatico. Laureato e dottorato all’Università di Buenos Aires, lavora in Francia dal 1991 presso l’INSERM, dove ha raggiunto il grado di Direttore di Ricerca di Classe Eccezionale. Co-dirige il gruppo “Biologia del cancro pancreatico” al CRCM di Marsiglia e presiede il Programma G7 Cancer. Fondatore di tre start-up biotecnologiche, ha pubblicato 472 articoli con oltre 43.500 citazioni 📚. La sua missione è migliorare la prognosi del tumore pancreatico attraverso ricerca e innovazione terapeutica.

Publication Profile

orcid

Education

Prof. Dr. Juan Iovanna began his academic journey with a degree in Medicine from the University of Buenos Aires, Argentina, in 1982. Driven by a passion for biomedical research, he pursued a Ph.D. in Biomedical Sciences at the same university, which he completed in 1986. 🧬 His doctoral thesis, titled “Meccanismi di regolazione della sintesi proteica in modelli cellulari di stress,” focused on the mechanisms regulating protein synthesis in cellular stress models. 🧪 This foundational work laid the groundwork for his future contributions to medical science and molecular biology.

Experience

🔬 Prof. Dr. Juan Iovanna has built an illustrious career in cancer research. In 1991, he began as a researcher at INSERM in France and was promoted to Research Director in 1993 and again in 1998. 🚀 In 2011, he achieved the prestigious title of Directeur de Recherche de Classe Exceptionnelle (DRCE). From 2011 to 2023, he served as Vice-Director of the Marseille Cancer Research Center (CRCM) and led its Translational Medicine Department. 🧫 He also directed the “Pancreatic Cancer Biology” group from 1999 to 2023. Since 2024, he co-directs this group with Dr. Nelson Dusetti and serves as Emeritus Research Director.

Distinctions and Awards

Prof. Dr. Juan Iovanna has received numerous prestigious awards and honors throughout his career. In 2017, he was awarded the Jean Valade Prize by the Fondation de France for his outstanding contributions to biomedical research. 🌍 In 2018, he received the RAICES Award from Argentina’s Ministry of Science, Technology, and Innovation. 🇫🇷 In 2021, the French Senate honored him with a commemorative medal. In 2023, he was named Honorary Professor at the National University Arturo Jauretche (UNAJ), and in 2024, he was recognized as a Distinguished and Honorary Member of the University of Buenos Aires.

Research Focus

Prof. Dr. Juan Iovanna’s research is centered on precision oncology, with a primary focus on pancreatic ductal adenocarcinoma (PDAC). His work integrates transcriptomics, drug resistance mechanisms, redox metabolism, and multi-omics modeling to uncover novel therapeutic vulnerabilities and biomarkers. He contributes to the development of RNA signatures (like GemPred) to predict chemotherapy response, and investigates KRAS inhibition and therapy-induced senescence as pathways to reverse drug resistance. His translational studies aim to optimize personalized treatment strategies for pancreatic cancer patients, bridging molecular insights with clinical application.

Publication Top Notes

KRAS inhibition reverses chemotherapy resistance promoted by therapy-induced senescence-like in pancreatic ductal adenocarcinoma

The PancreasView gemcitabine transcriptomic signature predicts response to gemcitabine in patients with resected pancreatic ductal adenocarcinoma

Adaptation of redox metabolism in drug-tolerant persister cells is a vulnerability to prevent relapse in pancreatic cancer

Reply to the Letter to the Editor regarding ‘Chi-squared and P-values vs. machine learning feature selection by Y. Takefuji’

Reply to the Letter to the Editor ‘AI-assisted personalized adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma’ by Y. Shimazu

Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial
Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity
Limitation and challenges in using pancreatic cancer‐derived organoids as a preclinical tool

Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction

Mario Leporace | Personalized Medicine | Best Innovation Award

Mario Leporace | Personalized Medicine | Best Innovation Award

Prof. Dr. Mario Leporace, Hospital and University, Italy

Prof. Dr. Mario Leporace is a distinguished Clinical Radiologist at the Department of Nuclear Medicine and Theragnostics, “Mariano Santo” Hospital, Cosenza, Italy. With expertise in oncologic imaging, hybrid and molecular imaging, and cardiovascular radiology, he is renowned for his advanced diagnostic work using X-ray, CT, MRI, PET/CT, and SPECT/CT. He holds a Master’s in Interventional Oncology and has contributed to over 15 peer-reviewed publications. His professional journey spans top institutions in Rome and Cosenza, marking a career dedicated to innovation in radiology and nuclear medicine.

Publication Profile

Scopus

Education

Prof. Dr. Mario Leporace 🎓 is a distinguished expert in interventional oncology and radiology. In 2022, he earned a Master’s Degree in Interventional Oncology from Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome, with a thesis on thermal ablation of bone metastases 🔥🦴. From 2001 to 2005, he completed his post-graduate certification in Radiology at the University of Rome “Tor Vergata” 🏥, graduating cum laude with a thesis on hybrid imaging 🧠📸. He also obtained his Degree in Medicine and Surgery from the same university (1995–2001), graduating with top honors and a thesis in vascular imaging 🫀🧬.

Experience

Prof. Dr. Mario Leporace 🩺 has an extensive career in radiology and nuclear medicine, showcasing over two decades of dedicated medical service. Since October 2017, he has been serving in the Department of Nuclear Medicine and Theragnostics at “Mariano Santo” Hospital in Cosenza, Italy ⚛️🏥. From May 2016 to September 2017, he worked at the Department of Radiology, “Annunziata” Hospital 🏨. Earlier, from March 2006 to April 2016, he contributed to the European Hospital in Rome, and concurrently, from November 2005 to April 2016, served at the Aurelia Hospital in Rome 🏛️🔬, strengthening his clinical expertise across institutions.

Research Focus

Prof. Dr. Mario Leporace focuses his research on Thermal Ablation with Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) 🔬🧠. His work bridges medical physics and oncological applications, exploring non-invasive treatments that use focused ultrasound energy to thermally ablate tumors with MRI precision guidance 🎯. This technique offers cutting-edge therapeutic possibilities in fields such as oncology, neurology, and women’s health 🧬💡. Prof. Leporace’s contributions advance both the clinical outcomes and technological innovation of MRgFUS, making him a key figure in image-guided therapy, minimally invasive surgery, and cancer treatment research .

Publication Top Notes

The Thermal Ablation with MRgFUS: From Physics to Oncological Applications

Mr. Sadik Abdulwehab|Personalized Medicine|Top Pharmaceutical Scientist Award

Mr. Sadik Abdulwehab-Personalized Medicine-Top Pharmaceutical Scientist Award

Mr. Sadik Abdulwehab at Wallaga University, Ethiopia

Author Profile

Orcid

Early Academic Pursuits 🎓

Sadik Abdulwehab Wake began his academic journey with a strong foundation in his hometown, Ethiopia. His primary education was completed at Oda Dannisa Elementary School (2001-2009), followed by secondary education at Digalu Secondary School (2010-2012). Demonstrating academic excellence, he progressed to Sagure Preparatory School in 2012-2013. He then embarked on his higher education at Wallega University, where he earned his Bachelor of Science (BSc) in Nursing in 2017 with an impressive cumulative GPA of 3.94.

His thirst for knowledge led him to pursue a Master’s degree in Adult Health Nursing (AHN) at Jimma University, which he successfully completed in 2024, achieving another remarkable GPA of 3.92. Currently, he is advancing his scholarly pursuits as a Ph.D. fellow, reflecting his dedication to continuous learning and academic excellence.

Professional Endeavors 🏥

Sadik has accumulated over six years of professional experience, including three and a half years in clinical nursing practice and three years in academia. During his clinical tenure, he honed his expertise in patient care, especially in adult health nursing, ensuring the delivery of high-quality healthcare services.

In the academic realm, Sadik has excelled as a lecturer, sharing his knowledge and inspiring the next generation of nursing professionals. His commitment to education is evident in his involvement in mentoring and supervising students on various research projects.

Sadik also contributed to national and international research efforts, collecting data for multiple NGOs and earning recognition for his contributions. His ability to blend clinical experience with academic prowess sets him apart as a multifaceted nursing professional.

Contributions and Research Focus 🔬

Sadik’s research interests span various critical areas in healthcare. His notable projects include:

  1. Blood Donation Awareness: Investigated the knowledge, attitude, and practice of medical and health science students at Wollega University regarding blood donation (2017).
  2. Patient Engagement in Decision-Making: Explored factors influencing patient involvement in healthcare decision-making at Jimma Medical Center (2023).
  3. Patient Autonomy in Asthma Management: Analyzed autonomy levels in managing bronchial asthma and associated factors at JMC (2023).
  4. Erectile Dysfunction in Type 1 Diabetes Patients: Studied its prevalence and associated factors among T1DM patients at JMC (2023).
  5. Workplace Violence in Nursing: Conducted a systematic review and meta-analysis on workplace violence against nurses in Ethiopia (2024).

These research endeavors demonstrate Sadik’s commitment to addressing significant challenges in nursing and healthcare, ultimately aiming to improve patient outcomes and the nursing profession.

Accolades and Recognition 🏅

Sadik’s dedication to his field has earned him numerous accolades, including:

  • Recognition letters and certificates for his contributions as a data collector for NGO projects.
  • Certification for completing a masterclass course with exceptional performance, further enhancing his professional credentials.

Impact and Influence 🌍

Sadik’s contributions have had a profound impact on healthcare and academia in Ethiopia. Through his research, he has provided valuable insights into critical issues such as patient autonomy, workplace violence in nursing, and healthcare decision-making. His work serves as a foundation for policy development and practical interventions to improve healthcare delivery.

In academia, his mentorship has guided many nursing students toward achieving their academic and professional goals. His influence extends beyond the classroom, shaping the future of nursing in Ethiopia.

Legacy and Future Contributions 🌟

As a Ph.D. fellow, Sadik aims to continue his journey of scholarly excellence and professional impact. His future goals include:

  • Advancing research in adult health nursing and other critical areas of healthcare.
  • Developing innovative solutions to address workplace challenges faced by nurses.
  • Contributing to global healthcare through collaborative research and knowledge exchange.

Sadik Abdulwehab Wake’s legacy lies in his unwavering commitment to nursing, education, and research. His journey inspires countless others to strive for excellence in the pursuit of improving lives through healthcare.

Closing Thoughts 💡

With a proven track record of academic achievements, professional expertise, and impactful research, Sadik embodies the qualities of a visionary nursing leader. His aspirations align with his commitment to serving society and advancing the nursing profession, making him an invaluable asset to any institution or organization.

Notable Publication

Engagement in healthcare decision-making and associated factors among patients with chronic non-communicable diseases in Southwest Ethiopia, 2023

  • Authors   : Sadik Abdulwehab; Yeshitila Belay; Frezer Kedir; Ebrahim Yimam; Admasu Belay
  • Journal    : Epidemiology and Global Health
  • Year         :2024

Patient autonomy in self-managing their bronchial asthma exacerbation and its associated factors, 2024

      • Authors   : adik Abdulwehab; Frezer Kedir
      • Journal    : Allergy
      • Year         :2024

Erectile Dysfunction and Associated Factors among Adult Diabetic Patients in Jimma Medical Center, Southwest, Ethiopia, 2023

  • Authors   : adik Abdulwehab

 

Prof Dr. Piotr Fiedor|Personalized Medicine|Best Researcher Award

Prof Dr. Piotr Fiedor|Personalized Medicine|Best Researcher Award

Prof Dr. Piotr Fiedor at Department of General and Transplantation Surgery, Medical University of Warsaw,Poland

PROFILE  

 

Scopus

Early Academic Pursuits 🎓

Professor Piotr Fiedor, MD, PhD, embarked on his medical journey with a strong focus on surgery and transplantation. His academic pursuits began at Warsaw Medical University, where he completed his initial medical training. Earning both his MD and PhD, Fiedor developed a passion for complex medical fields such as transplantation immunology and biotechnology. During his early career, he broadened his expertise with international fellowships, notably at Columbia University in the United States, between 1993 and 1996, where he deepened his knowledge in transplantation immunology and immunomodulation. This fellowship solidified his expertise and set the stage for his contributions to both academia and the field of transplantation surgery.

Professional Endeavors 🔬

Professor Fiedor’s professional career has been a blend of clinical practice, research, and leadership roles. Since 1995, he has served in the Department of General and Transplantation Surgery at Warsaw Medical University. His responsibilities in this department include managing clinical procedures, conducting high-level research, and overseeing scientific programs. In addition to his academic role, Fiedor held the prestigious position of Chief Executive Officer at the National Medicine Institute in Warsaw from 2015 to 2017. During this period, he was responsible for overseeing the evaluation of medicinal products, ensuring high-quality standards, and coordinating with the European Directorate for the Quality of Medicines & HealthCare (EDQM).

Fiedor’s influence extends to regulatory affairs, particularly as the Polish Member of the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) from 2010 to 2017. His contributions in the CHMP involved acting as Rapporteur or Co-Rapporteur for more than 120 innovative medicinal products, ensuring their safe and effective use across Europe. His regulatory expertise continues, as he now serves as an Expert for the CHMP Scientific Advice Group.

Contributions and Research Focus 🧬

Professor Fiedor’s research has had a profound impact on the fields of transplant surgery, oncology, and immunology. His scientific work has addressed critical challenges in organ transplantation, including the immunological complications of transplants and strategies for improving graft survival. His work on the hemodynamic changes in organ donors before harvesting has been particularly influential, contributing to improved transplantation outcomes.

International collaborations have been a cornerstone of his research. He has worked with institutions like L’Aquila University in Italy, Columbia University and Ohio State University in the United States, and the Hebrew University of Jerusalem in Israel. His participation in 15 national scientific projects supported by Poland’s National Scientific Committee and two research grants from the National Institutes of Health (NIH) in the USA highlight his commitment to advancing medical science on a global scale.

Accolades and Recognition 🏅

Throughout his career, Professor Fiedor has received numerous awards recognizing his contributions to medical science, education, and public health. Some of his most notable honors include:

  • The Gold Cross of Merit awarded by the President of Poland in 2011 for his exceptional service to medicine.
  • The National Education Committee Medal in 2009 for his contributions to the advancement of medical education.
  • Multiple scientific awards from Warsaw Medical University, including team and individual awards for groundbreaking research on organ transplantation and immunology.
  • A notable achievement is his 2012 First-Degree Team Teaching Award from the Rector of Warsaw Medical University for co-authoring a textbook on disaster medicine.

These awards underline his influence on both medical practice and education.

Impact and Influence 🌍

Professor Fiedor’s impact extends beyond his clinical and research achievements. As a member of international organizations like the International Transplantation Society and the American Society of Transplant Surgeons (ASTS), he has helped shape the global discourse on transplant surgery and immunology. His work has led to significant advances in transplantation procedures, particularly concerning immunosuppressive therapies that reduce the risk of organ rejection.

In addition to his clinical and research accomplishments, Fiedor has played a vital role in shaping regulatory policies for medicinal products in Poland and Europe. His expertise in clinical trials, particularly through his work at the National Medicines Institute and his leadership in Good Clinical Practice (GCP) inspections, has influenced the standards of medical product approvals across Europe.

Legacy and Future Contributions 🌟

Professor Fiedor’s legacy lies in his multifaceted contributions to medicine. He has influenced generations of surgeons and medical professionals through his teaching roles at Warsaw Medical University. His over 210 scientific papers and 19 book chapters serve as valuable resources for both current and future medical researchers. His dedication to personalized medicine and biotechnology continues through his involvement in organizations such as the International Consortium for Personalized Medicine (IC PerMed), where he plays a role in advancing tailored healthcare solutions.

Looking forward, Fiedor’s ongoing work with European Joint Programs for Rare Diseases and the National Center for Research and Development’s Alpha Bridge Project ensures that he will continue to contribute to innovative research in the field of rare diseases and healthy society initiatives.

Conclusion 🔖

Professor Piotr Fiedor’s career stands as a testament to his dedication to the fields of surgery, immunology, and transplantation. With a rich history of academic achievements, clinical leadership, and regulatory expertise, his contributions have reshaped modern medicine, particularly in the realms of organ transplantation and medicinal product evaluation. His legacy continues to inspire both his peers and the next generation of medical professionals.

🎓Publication 

One Molecule, Many Faces: Repositioning Cardiovascular Agents for Advanced Wound Healing

  • Authors   : Gościniak, A., Stasiłowicz-Krzemień, A., Michniak-Kohn, B., Fiedor, P., Cielecka-Piontek, J.
  • Journal    :Molecules
  • Year         :2024

Are Current Educational and Therapeutic Programs, Directed at Rare Disease Transplant Candidates and Recipients, Sufficient to Support Them on the Path From Diagnosis to Life After Allogenic Transplantation?—Recommendations for Member State Policymakers

  • Authors   : Bartoszewicz, M., Prokop, P., Kosieradzki, M., Fiedor, P.
  • Journal    :Transplantation Proceedings
  • Year         :2024

Comparison of Long-Term Outcomes of Surgical Treatment of Human Papillomavirus-Dependent Neoplastic Lesions in Patients With Chronic Immunosuppression After Allogenic Organ Transplantation and Patients With Primary or Acquired Immunodeficiency—A One-Center Experience

  • Authors   : Prokop, P., Bartoszewicz, M., Gardyszewska, A., Kosieradzki, M., Fiedor, P.
  • Journal    :ransplantation Proceedings
  • Year         :2024

Amantadine in unvaccinated patients with early, mild to moderate COVID-19: A randomized, placebo-controlled, double-blind trial

  • Authors   :Rejdak, K., Fiedor, P., Bonek, R., Kaczor, M., Grieb, P.
  • Journal    :European Journal of Neurology
  • Year         :2024

POLCOVID: a multicenter multiclass chest X-ray database (Poland, 2020–2021)

  • Authors   :Suwalska, A., Tobiasz, J., Prazuch, W., Cieszanowski, A., Polanska, J.
  • Year         :2023

Mrs. Ana Catarina Sousa| Personalized Medicine|Best Researcher Award

Mrs. Ana Catarina Sousa| Personalized Medicine|Best Researcher Award

Mrs. Ana Catarina Sousa at School of Medicine and Biomedical Sciences – University of Porto (ICBAS),Portugal

PROFILE  

Google scholar

Early Academic Pursuits 🎓

Ana Catarina Soares de Sousa’s academic journey is marked by a strong focus on the intersection of healthcare and engineering. She completed her Master’s degree in Health Services Management and Economics in 2021 at the prestigious University of Porto, one of the top academic institutions in Portugal. This degree provided her with in-depth knowledge of the economic and managerial aspects of healthcare services, a vital skill set for navigating the complexities of healthcare systems and improving service delivery.

Prior to this, she earned a Master’s degree in Integrated Master in Bioengineering in 2018 at the same university. This program combined principles of biology, medicine, and engineering, equipping her with a solid foundation in biomedical engineering—particularly crucial for her subsequent research on biomaterials and medical technologies. Her dual educational background uniquely positions her to address both the technical and systemic challenges in health services, a hallmark of her later work.

Since 2020, Ana Catarina has been pursuing a PhD in Biomedical Sciences at the Abel Salazar Institute of Biomedical Sciences (ICBAS) within the University of Porto. Her PhD program focuses on interdisciplinary research in medical and health sciences, allowing her to build on her expertise in biomaterials and tissue engineering, while contributing to innovations in medical biotechnology.

Professional Endeavors 💼

Ana Catarina’s professional journey reflects a commitment to both research and practical applications in the biomedical sciences. Throughout her career, she has participated in numerous research projects, taking on key roles both as a research fellow and a lead researcher. Since 2018, she has contributed to seven major research projects, focusing on cutting-edge biomedical technologies and solutions for healthcare challenges.

Among her significant projects are:

  • InnovaBIOMAS (2023–2026): An innovative biofabrication system for creating multi-tissue scaffolds for joint disease treatments. This project highlights her expertise in biomaterials and tissue engineering.
  • H2Cure (2021–2024): A project developing novel formulations, including honey-based gels and dressings with gelan gum and hyaluronic acid for wound care—an intersection of regenerative medicine and biotechnology.
  • PRECOGFIL (2020–2024): This initiative explores the development of pre-tensioned cog threads for transvaginal repair of compartment prolapse, showing her application of bioengineering in women’s health.
  • Bone2Move (2018–2021): Focused on 4D scaffolds for bone defect repair, it underscores her involvement in the evolution of tissue engineering techniques.

Her work has crossed the boundaries of disciplines, spanning medical technology, veterinary applications, regenerative medicine, and materials engineering.

Contributions and Research Focus 🔬

Ana Catarina’s contributions to the biomedical field have been prolific. With 30 peer-reviewed journal articles and 2 book chapters, she has established herself as a thought leader in the scientific community. Her research encompasses a range of fields, but she is particularly recognized for her work in Medical Biotechnology, with a specific emphasis on biomaterials and tissue engineering.

Some of the key areas of her research include:

  • Regenerative Medicine: Her focus on developing advanced biomaterials that can aid in tissue regeneration and healing has practical applications in orthopedics, wound care, and surgical interventions.
  • Veterinary Medicine: Her interdisciplinary approach extends into veterinary science, where she applies biomedical engineering techniques to animal health.
  • Translational Medicine: Ana Catarina is committed to bridging the gap between laboratory research and clinical applications, ensuring that her discoveries can have a real-world impact on patient care.
  • Sustainable Chemistry: She has also been involved in developing environmentally friendly materials and chemical processes for healthcare applications, contributing to sustainability in medical technology.
  • Chemistry for Health: Her work in this area includes the development of biomaterials and formulations aimed at improving health outcomes through innovative chemistry.

With 214 co-authors in her published works, she has demonstrated an impressive ability to collaborate across disciplines and with researchers from around the world.

Accolades and Recognition 🏆

Ana Catarina’s work has not gone unnoticed. She has been the recipient of one award that recognizes her contributions to the field of biomedical sciences. This accolade highlights her innovative approach to healthcare challenges and her ability to bring together diverse disciplines in pursuit of improved health outcomes.

In addition to her award, she has also been instrumental in the scientific community as an event organizer. She has successfully organized three major events, bringing together researchers, healthcare professionals, and industry experts to discuss the latest advancements in biomedical sciences and medical technologies.

Impact and Influence 🌍

Ana Catarina’s work in biomedical sciences has the potential to make a far-reaching impact on both human and animal health. By focusing on innovative biomaterials and medical biotechnology, she is contributing to the development of new treatments that could transform the way diseases are managed and treated. Her research on scaffold-based tissue regeneration and wound care formulations has implications for patients suffering from joint diseases, chronic wounds, and surgical complications.

Her work in the development of advanced biofabrication systems and pre-tensioned threads for surgical repairs also promises to improve surgical outcomes and post-surgical recovery for patients. Moreover, her focus on sustainable chemical processes ensures that her contributions are not only medically valuable but also environmentally responsible.

Legacy and Future Contributions 🌟

Looking ahead, Ana Catarina is poised to continue making groundbreaking contributions to the field of biomedical sciences. Her ongoing projects, particularly those related to biomaterials for regenerative medicine, have the potential to lead to new therapies that will benefit both human and veterinary medicine.

Her focus on translational research ensures that her work will continue to have a direct impact on clinical practices, making her a key figure in the future of medical biotechnology. As she progresses in her PhD journey and beyond, Ana Catarina Soares de Sousa is likely to leave a lasting legacy in the fields of tissue engineering and healthcare innovation.

In the years to come, her work is expected to influence not only scientific research but also the development of new medical technologies that will improve patient care and healthcare systems around the world.

🎓Publication 

Peripheral nerve injury treatments and advances: one health perspective

  • Authors   :Bruna Lopes, Patrícia Sousa, Rui Alvites, Mariana Branquinho, Ana Catarina Sousa, Carla Mendonça, Luís Miguel Atayde, Ana Lúcia Luís, Artur SP Varejão, Ana Colette Maurício
  • Journal    :International journal of molecular sciences
  • Year         :2022

Dental pulp stem cells and Bonelike® for bone regeneration in ovine model

  • Authors   : JM Campos, AC Sousa, AR Caseiro, SS Pedrosa, PO Pinto, MV Branqu
  • Journal    :Regenerative biomaterials
  • Year         :2019

Mesenchymal stem/stromal cells and their paracrine activity—immunomodulation mechanisms and how to influence the therapeutic potential

  • Authors   : Rui Alvites, Mariana Branquinho, Ana C Sousa, Bruna Lopes, Patrícia Sousa, Ana Colette Maurício
  • Journal    :Pharmaceutics
  • Year         :2022

Assessment of the environmental impacts of medical devices: a review

  • Authors   :Ana Catarina Sousa, Anabela Veiga, Ana Collete Maurício, Maria Ascensão Lopes, José Domingos Santos, Belmira Neto
  • Journal    :Environment, Development and Sustainability
  • Year         :2021

Combined Use of Chitosan and Olfactory Mucosa Mesenchymal Stem/Stromal Cells to Promote Peripheral Nerve Regeneration In Vivo

  • Authors   :Rui D Alvites, Mariana V Branquinho, Ana C Sousa, Irina Amorim, Rui Magalhães, Filipa João, Diogo Almeida, Sandra Amado, Justina Prada, Isabel Pires, Federica Zen, Stefania Raimondo, Ana L Luís, Stefano Geuna, Artur SP Varejão, Ana C Maurício
  • Journal    :Stem cells international
  • Year         :2021